Hedge funds and other institutional investors own 88.14% of the company’s stock. Vanda Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and Anaptys Here is how AnaptysBio, Inc. (ANAB) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year.
SAN DIEGO - AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company currently trading near its 52-week low at $12.38, announced significant findings from their Phase 2b RENOIR trial for ...
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 ...
At close: 7 February at 7:30:44 pm GMT+1 ...
After hours: February 7 at 7:23:36 PM EST ...
After hours: February 10 at 6:56:42 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback